Exploring the Human Cytomegalovirus Core Nuclear Egress Complex as a Novel Antiviral Target: A New Type of Small Molecule Inhibitors
Open Access
Abstract
Nuclear egress is an essential process in the replication of human cytomegalovirus (HCMV), as it enables the migration of newly formed viral capsids from the nucleus into the cytoplasm. Inhibition of the HCMV core nuclear egress complex (core NEC), composed of viral proteins pUL50 and pUL53, has been proposed as a potential new target for the treatment of HCMV infection and disease. Here, we present a new type of small molecule inhibitors of HCMV core NEC formation, which inhibit the pUL50-pUL53 interaction at nanomolar concentrations. These inhibitors, i.e., verteporfin and merbromin, were identified through the screening of the Prestwick Chemical Library® of approved drug compounds. The inhibitory effect of merbromin is both compound- and target-specific, as no inhibition was seen for other mercury-organic compounds. Furthermore, merbromin does not inhibit an unrelated protein–protein interaction either. More importantly, merbromin was found to inhibit HCMV infection of cells in three different assays, as well as to disrupt HCMV NEC nuclear rim formation. Thus, while not being an ideal drug candidate by itself, merbromin may serve as a blueprint for small molecules with high HCMV core NEC inhibitory potential, as candidates for novel anti-herpesviral drugs.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (EI 423/4-1, MA 1289/8-1, MU 1477/10-1)
This publication has 30 references indexed in Scilit:
- Cytomegalovirus pUL50 is the multi-interacting determinant of the core nuclear egress complex (NEC) that recruits cellular accessory NEC componentsJournal of General Virology, 2016
- Crystal Structure of the Human Cytomegalovirus pUL50-pUL53 Core Nuclear Egress Complex Provides Insight into a Unique Assembly Scaffold for Virus-Host Protein InteractionsJournal of Biological Chemistry, 2015
- Unexpected features and mechanism of heterodimer formation of a herpesvirus nuclear egress complexThe EMBO Journal, 2015
- Proteomic Analysis of the Multimeric Nuclear Egress Complex of Human CytomegalovirusMolecular & Cellular Proteomics, 2014
- Mimicking Protein–Protein Interactions through Peptide–Peptide Interactions: HIV-1 gp120 and CXCR4Frontiers in Immunology, 2013
- A cell free protein fragment complementation assay for monitoring the core interaction of the human cytomegalovirus nuclear egress complexAntiviral Research, 2012
- A Functionally Selective Synthetic Mimic of the HIV‐1 Co‐receptor CXCR4Chemistry – A European Journal, 2012
- In VitroActivity of Thimerosal against Ocular Pathogenic FungiAntimicrobial Agents and Chemotherapy, 2010
- VerteporfinDrugs & Aging, 2000
- A new mercurial diuretic*Journal of the American Pharmaceutical Association (Scientific ed.), 1951